Cargando…
The prognostic efficacy of cell-free DNA hypermethylation in colorectal cancer
Epigenetic alterations in colorectal cancer (CRC) cause important differences in the underlying tumor biology and aggressiveness. DNA hypermethylation is central for the development of CRC but the prognostic impact remains elusive. We aimed to assess the association between cell-free hypermethylated...
Autores principales: | Rasmussen, Simon Ladefoged, Krarup, Henrik Bygum, Sunesen, Kåre Gotschalck, Johansen, Martin Berg, Stender, Mogens Tornby, Pedersen, Inge Søkilde, Madsen, Poul Henning, Thorlacius-Ussing, Ole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805532/ https://www.ncbi.nlm.nih.gov/pubmed/29467946 http://dx.doi.org/10.18632/oncotarget.24097 |
Ejemplares similares
-
Hypermethylated DNA, a circulating biomarker for colorectal cancer detection
por: Rasmussen, Simon Ladefoged, et al.
Publicado: (2017) -
High recovery of cell-free methylated DNA based on a rapid bisulfite-treatment protocol
por: Pedersen, Inge Søkilde, et al.
Publicado: (2012) -
Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma
por: Henriksen, Stine Dam, et al.
Publicado: (2017) -
Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma
por: Henriksen, Stine Dam, et al.
Publicado: (2016) -
Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma
por: Stubbe, Benjamin Emil, et al.
Publicado: (2021)